Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants
Research Article
[키워드] 2003
acute respiratory syndrome
addition
Administered
Antisera
bat
bats
Bearing
candidate vaccine
caused
Cell
cellular immune responses
center
characterized
chimeric
China
Cluster
coding
Complete
Consequences
Control
coronavirus
cross
death
death rate
death rates
develop
died
different
disease
effective
Efficacy
eight
elicit
Epidemic
etiological agent
examined
expressing
finding
flu
found
future infection
Gene
genetic material
genetics
glycoprotein
group
Guidance
Heterologous
heterologous challenge
homologous
homologous or heterologous
homologous strain challenge
Human
human airway epithelial
humans
identify
immune response
immunized
immunopathology
infect
Infected
Infection
information
injected
lung
mice
much higher
neutralization
nucleocapsid
Older
Outbreaks
Particle
pathological change
pathology
peaked
phylogenetic analyses
populations
PROTECT
Protein
Proteins
provide
provided
recombinant
related virus
related viruses
replicated
researcher
reservoirs
resource
robust
rodents
S glycoprotein
SARS Coronavirus
SARS infection
SARS virus
SARS-CoV
SARS-CoV N
SARS-CoV S
SARS-CoV S protein
SARS-CoV vaccine
SARS-CoV virus
senescent
severe
severe pneumonia
spike
spike glycoprotein
Spread
strain
Strains
tested
the disease
the vaccine
thought
vaccination
Vaccine
vaccine candidate
Vaccine design
Vaccine development
Vaccines
variant
Venezuelan equine encephalitis
virus
virus strain
was used
Web
West Nile Virus
World Health Organization
zoonosis
zoonotic
[DOI] 10.1371/journal.pmed.0030525 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pmed.0030525 PMC 바로가기 [Article Type] Research Article